BSX Boston Scientific
NYSE · SEC CIK 885725 · EDGAR
- Bought, last 12 months
- $10.04M 8 purchases by 5 insiders
- Sold, last 12 months
- $29.27M 6 sales by 4 insiders
- Filings on record
- 526 since 2021-07-06, latest 2026-09-03 16:34
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Mahoney Michael F | COB, Pres, CEO, Dir | $9.00M | $15.04M |
| Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | — | $9.90M |
| Zane Ellen M | Dir | — | $2.57M |
| Butcher Arthur C | EVP, Grp Pres, MedSurg, APAC | — | $1.76M |
| LUDWIG EDWARD J | Dir | $430.3K | — |
| Habiger David C | Dir | $407.9K | — |
| Morano Susan E | Dir | $100.4K | — |
| Pegus Cheryl | Dir | $100.0K | — |
| O'Connor Padraig Andrew | EVP, Gbl Ops | — | — |
| O'Sullivan Miriam | SVP, Chief HR Off | — | — |
Transactions 847
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-05-06 | 2022-05-05 | BSX | ROUX DAVID J | Dir | A - Grant | $0.00 | +4,877 | 69.6K | +8% | $0 | |
| 2022-05-06 | 2022-05-05 | BSX | Connors Nelda J | Dir | A - Grant | $0.00 | +4,877 | 16.0K | +44% | $0 | |
| D | 2022-05-02 | 2022-05-01 | BSX | Scanlon Meghan | SVP, Pres, Urology Pelvic Health | M - OptEx | $0.00 | +2,062 | 25.1K | +9% | $0 |
| D | 2022-05-02 | 2022-05-01 | BSX | Scanlon Meghan | SVP, Pres, Urology Pelvic Health | F - Tax | $42.11 | -606 | 24.5K | -2% | -$25.5K |
| 2022-04-21 | 2022-04-20 | BSX | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | S - Sale | $46.50 | -9,645 | 110.3K | -8% | -$448.5K | |
| 2022-04-20 | 2022-04-19 | BSX | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | S - Sale | $45.50 | -11.0K | 120.0K | -8% | -$500.0K | |
| 2022-04-14 | 2022-04-14 | BSX | Carruthers Wendy | EVP, Human Resources | S - Sale | $44.47 | -7,500 | 147.4K | -5% | -$333.5K | |
| 2022-04-04 | 2022-04-01 | BSX | Eddy Jodi Euerle | SVP, Chief Info, Digital Off | S - Sale | $45.00 | -2,779 | 23.3K | -11% | -$125.1K | |
| 2022-04-01 | 2022-04-01 | BSX | Olson Scott | SVP, Pres, CRM, Diagnostics | S - Sale | $44.55 | -700 | 14.5K | -5% | -$31.2K | |
| D | 2022-03-31 | 2022-03-29 | BSX | Butcher Arthur C | EVP, Pres, Asia Pacific | M - OptEx | $16.31 | +5,411 | 40.5K | +15% | +$88.3K |
| D | 2022-03-31 | 2022-03-29 | BSX | Butcher Arthur C | EVP, Pres, Asia Pacific | S - Sale+OE | $45.00 | -10.3K | 30.3K | -25% | -$462.1K |
| 2022-03-29 | 2022-03-28 | BSX | Meredith Ian T | EVP Gbl Chief Med Off | S - Sale | $43.68 | -6,588 | 28.1K | -19% | -$287.8K | |
| 2022-03-23 | 2022-03-22 | BSX | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | S - Sale | $44.50 | -11.2K | 130.9K | -8% | -$500.0K | |
| 2022-03-16 | 2022-03-15 | BSX | Carruthers Wendy | EVP, Human Resources | S - Sale | $42.34 | -7,500 | 154.9K | -5% | -$317.6K | |
| D | 2022-03-07 | 2022-03-03 | BSX | Fitzgerald Joseph Michael | EVP, Pres, Cardiology | M - OptEx | $0.00 | +3,603 | 219.7K | +2% | $0 |
| D | 2022-03-07 | 2022-03-03 | BSX | Fitzgerald Joseph Michael | EVP, Pres, Cardiology | F - Tax | $43.96 | -1,779 | 217.9K | -0.8% | -$78.2K |
| 2022-03-03 | 2022-03-02 | BSX | Brennan Daniel J. | EVP, CFO | S - Sale | $44.03 | -11.0K | 264.3K | -4% | -$485.6K | |
| D | 2022-03-02 | 2022-02-28 | BSX | Mahoney Michael F | COB, Pres, CEO, Dir | F - Tax | $44.17 | -8,130 | 2.13M | -0.4% | -$359.1K |
| D | 2022-03-02 | 2022-02-28 | BSX | Mahoney Michael F | COB, Pres, CEO, Dir | M - OptEx | $0.00 | +18.3K | 2.14M | +0.9% | $0 |
| D | 2022-03-02 | 2022-02-28 | BSX | Sorenson John Bradley | SVP, Gbl Supply Chain | M - OptEx | $0.00 | +1,222 | 37.4K | +3% | $0 |
| D | 2022-03-02 | 2022-02-28 | BSX | Sorenson John Bradley | SVP, Gbl Supply Chain | F - Tax | $44.17 | -374 | 37.0K | -1.0% | -$16.5K |
| D | 2022-03-02 | 2022-02-28 | BSX | Thepaut Eric Francis Yves | EVP, Pres, Eur, Mid-East, Afr | F - Tax | $44.17 | -1,031 | 93.2K | -1% | -$45.5K |
| D | 2022-03-02 | 2022-02-28 | BSX | Thepaut Eric Francis Yves | EVP, Pres, Eur, Mid-East, Afr | M - OptEx | $0.00 | +1,833 | 94.2K | +2% | $0 |
| D | 2022-03-02 | 2022-02-28 | BSX | Nanavaty Maulik | SVP, Pres, Neuromodulation | M - OptEx | $0.00 | +1,630 | 177.8K | +0.9% | $0 |
| D | 2022-03-02 | 2022-02-28 | BSX | Nanavaty Maulik | SVP, Pres, Neuromodulation | F - Tax | $44.17 | -564 | 177.3K | -0.3% | -$24.9K |
| D | 2022-03-02 | 2022-02-28 | BSX | Eddy Jodi Euerle | SVP, Chief Info, Digital Off | F - Tax | $44.17 | -419 | 26.0K | -2% | -$18.5K |
| D | 2022-03-02 | 2022-02-28 | BSX | Eddy Jodi Euerle | SVP, Chief Info, Digital Off | M - OptEx | $0.00 | +1,426 | 26.5K | +6% | $0 |
| D | 2022-03-02 | 2022-02-28 | BSX | Meredith Ian T | EVP Gbl Chief Med Off | M - OptEx | $0.00 | +1,019 | 35.0K | +3% | $0 |
| D | 2022-03-02 | 2022-02-28 | BSX | Meredith Ian T | EVP Gbl Chief Med Off | F - Tax | $44.17 | -300 | 34.7K | -0.9% | -$13.3K |
| D | 2022-03-02 | 2022-02-28 | BSX | Brennan Daniel J. | EVP, CFO | F - Tax | $44.17 | -1,988 | 275.3K | -0.7% | -$87.8K |
| D | 2022-03-02 | 2022-02-28 | BSX | Brennan Daniel J. | EVP, CFO | M - OptEx | $0.00 | +4,481 | 277.3K | +2% | $0 |
| D | 2022-03-02 | 2022-02-28 | BSX | Mackey Edward F | EVP, Ops | F - Tax | $44.17 | -1,084 | 52.9K | -2% | -$47.9K |
| D | 2022-03-02 | 2022-02-28 | BSX | Mackey Edward F | EVP, Ops | M - OptEx | $0.00 | +2,444 | 54.0K | +5% | $0 |
| D | 2022-03-02 | 2022-02-28 | BSX | Olson Scott | SVP, Pres, CRM, Diagnostics | M - OptEx | $0.00 | +1,426 | 16.0K | +10% | $0 |
| D | 2022-03-02 | 2022-02-28 | BSX | Olson Scott | SVP, Pres, CRM, Diagnostics | F - Tax | $44.17 | -766 | 15.2K | -5% | -$33.8K |
| D | 2022-03-02 | 2022-02-28 | BSX | Pierce David A | EVP Pres MedSurg | F - Tax | $44.17 | -718 | 1,726 | -29% | -$31.7K |
| D | 2022-03-02 | 2022-02-28 | BSX | Pierce David A | EVP Pres MedSurg | M - OptEx | $0.00 | +2,444 | 2,444 | New | $0 |
| D | 2022-03-02 | 2022-03-01 | BSX | Pierce David A | EVP Pres MedSurg | S - Sale+OE | $43.94 | -1,726 | 0 | -100% | -$75.8K |
| D | 2022-03-02 | 2022-02-28 | BSX | Scanlon Meghan | SVP, Pres, Urology Pelvic Health | M - OptEx | $0.00 | +1,019 | 23.3K | +5% | $0 |
| D | 2022-03-02 | 2022-02-28 | BSX | Scanlon Meghan | SVP, Pres, Urology Pelvic Health | F - Tax | $44.17 | -300 | 23.0K | -1% | -$13.3K |
| D | 2022-03-02 | 2022-02-28 | BSX | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | M - OptEx | $0.00 | +2,037 | 142.8K | +1% | $0 |
| D | 2022-03-02 | 2022-02-28 | BSX | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | F - Tax | $44.17 | -624 | 142.2K | -0.4% | -$27.6K |
| D | 2022-03-02 | 2022-02-28 | BSX | Brown Vance R | SVP, GC, Corp. Sec | F - Tax | $44.17 | -300 | 32.8K | -0.9% | -$13.3K |
| D | 2022-03-02 | 2022-02-28 | BSX | Brown Vance R | SVP, GC, Corp. Sec | M - OptEx | $0.00 | +1,019 | 33.1K | +3% | $0 |
| D | 2022-03-02 | 2022-02-28 | BSX | Monson Jonathan | VP, CAO, Gbl Ctrl | M - OptEx | $0.00 | +815 | 31.6K | +3% | $0 |
| D | 2022-03-02 | 2022-02-28 | BSX | Monson Jonathan | VP, CAO, Gbl Ctrl | F - Tax | $44.17 | -238 | 31.3K | -0.8% | -$10.5K |
| D | 2022-03-02 | 2022-02-28 | BSX | Butcher Arthur C | EVP, Pres, Asia Pacific | M - OptEx | $0.00 | +1,528 | 35.8K | +4% | $0 |
| D | 2022-03-02 | 2022-02-28 | BSX | Butcher Arthur C | EVP, Pres, Asia Pacific | F - Tax | $44.17 | -640 | 35.1K | -2% | -$28.3K |
| D | 2022-03-02 | 2022-02-28 | BSX | Carruthers Wendy | SVP, Human Resources | F - Tax | $44.17 | -479 | 162.4K | -0.3% | -$21.2K |
| D | 2022-03-02 | 2022-02-28 | BSX | Carruthers Wendy | SVP, Human Resources | M - OptEx | $0.00 | +1,630 | 162.9K | +1% | $0 |
| D | 2022-03-02 | 2022-02-23 | BSX | Carruthers Wendy | SVP, Human Resources | G - Gift | $0.00 | -2,300 | 161.3K | -1% | $0 |
| DM | 2022-02-24 | 2022-02-22+ | BSX | Pierce David A | EVP Pres MedSurg | S - Sale | $42.90 | -3,645 | 0 | -100% | -$156.4K |
| DM | 2022-02-24 | 2022-02-22 | BSX | Brennan Daniel J. | EVP, CFO | M - OptEx | $14.51 | +53.2K | 326.0K | +19% | +$771.8K |
| D | 2022-02-24 | 2022-02-22 | BSX | Brennan Daniel J. | EVP, CFO | S - Sale+OE | $42.75 | -53.2K | 272.8K | -16% | -$2.27M |
| D | 2022-02-23 | 2022-02-21 | BSX | Mahoney Michael F | COB, Pres, CEO, Dir | F - Tax | $42.55 | -7,462 | 2.12M | -0.4% | -$317.5K |
| D | 2022-02-23 | 2022-02-21 | BSX | Mahoney Michael F | COB, Pres, CEO, Dir | M - OptEx | $0.00 | +16.8K | 2.13M | +0.8% | $0 |
| D | 2022-02-23 | 2022-02-21 | BSX | Meredith Ian T | EVP Gbl Chief Med Off | F - Tax | $42.55 | -298 | 34.0K | -0.9% | -$12.7K |
| D | 2022-02-23 | 2022-02-21 | BSX | Meredith Ian T | EVP Gbl Chief Med Off | M - OptEx | $0.00 | +1,013 | 34.2K | +3% | $0 |
| D | 2022-02-23 | 2022-02-21 | BSX | Carruthers Wendy | SVP, Human Resources | M - OptEx | $0.00 | +1,558 | 164.0K | +1.0% | $0 |
| D | 2022-02-23 | 2022-02-21 | BSX | Carruthers Wendy | SVP, Human Resources | F - Tax | $42.55 | -458 | 163.6K | -0.3% | -$19.5K |
| D | 2022-02-23 | 2022-02-21 | BSX | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | F - Tax | $42.55 | -859 | 140.8K | -0.6% | -$36.6K |
| D | 2022-02-23 | 2022-02-21 | BSX | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | M - OptEx | $0.00 | +2,804 | 141.6K | +2% | $0 |
| D | 2022-02-23 | 2022-02-21 | BSX | Olson Scott | SVP, Pres, CRM, Diagnostics | M - OptEx | $0.00 | +1,090 | 15.2K | +8% | $0 |
| D | 2022-02-23 | 2022-02-21 | BSX | Olson Scott | SVP, Pres, CRM, Diagnostics | F - Tax | $42.55 | -606 | 14.6K | -4% | -$25.8K |
| D | 2022-02-23 | 2022-02-21 | BSX | Butcher Arthur C | EVP, Pres, Asia Pacific | F - Tax | $42.55 | -718 | 34.2K | -2% | -$30.6K |
| D | 2022-02-23 | 2022-02-21 | BSX | Butcher Arthur C | EVP, Pres, Asia Pacific | M - OptEx | $0.00 | +1,714 | 35.0K | +5% | $0 |
| D | 2022-02-23 | 2022-02-21 | BSX | Sorenson John Bradley | SVP, Gbl Supply Chain | M - OptEx | $0.00 | +1,090 | 36.5K | +3% | $0 |
| D | 2022-02-23 | 2022-02-21 | BSX | Sorenson John Bradley | SVP, Gbl Supply Chain | F - Tax | $42.55 | -334 | 36.2K | -0.9% | -$14.2K |
| D | 2022-02-23 | 2022-02-21 | BSX | Pierce David A | EVP Pres MedSurg | F - Tax | $42.55 | -732 | 3,645 | -17% | -$31.1K |
| D | 2022-02-23 | 2022-02-21 | BSX | Pierce David A | EVP Pres MedSurg | M - OptEx | $0.00 | +2,493 | 4,377 | +132% | $0 |
| D | 2022-02-23 | 2022-02-21 | BSX | Eddy Jodi Euerle | SVP, Chief Info, Digital Off | M - OptEx | $0.00 | +935 | 25.3K | +4% | $0 |
| D | 2022-02-23 | 2022-02-21 | BSX | Eddy Jodi Euerle | SVP, Chief Info, Digital Off | F - Tax | $42.55 | -275 | 25.0K | -1% | -$11.7K |
| D | 2022-02-23 | 2022-02-21 | BSX | Brown Vance R | SVP, GC, Corp. Sec | F - Tax | $42.55 | -230 | 32.0K | -0.7% | -$9,786 |
| D | 2022-02-23 | 2022-02-21 | BSX | Brown Vance R | SVP, GC, Corp. Sec | M - OptEx | $0.00 | +779 | 32.3K | +2% | $0 |
| D | 2022-02-23 | 2022-02-21 | BSX | Nanavaty Maulik | SVP, Pres, Neuromodulation | F - Tax | $42.55 | -593 | 176.2K | -0.3% | -$25.2K |
| D | 2022-02-23 | 2022-02-21 | BSX | Nanavaty Maulik | SVP, Pres, Neuromodulation | M - OptEx | $0.00 | +1,714 | 176.8K | +1.0% | $0 |
| D | 2022-02-23 | 2022-02-21 | BSX | Mackey Edward F | EVP, Ops | F - Tax | $42.55 | -1,209 | 51.6K | -2% | -$51.4K |
| D | 2022-02-23 | 2022-02-21 | BSX | Mackey Edward F | EVP, Ops | M - OptEx | $0.00 | +2,726 | 52.8K | +5% | $0 |
| D | 2022-02-23 | 2022-02-21 | BSX | Thepaut Eric Francis Yves | EVP, Pres, Eur, Mid-East, Afr | M - OptEx | $0.00 | +1,714 | 93.3K | +2% | $0 |
| D | 2022-02-23 | 2022-02-21 | BSX | Thepaut Eric Francis Yves | EVP, Pres, Eur, Mid-East, Afr | F - Tax | $42.55 | -964 | 92.4K | -1% | -$41.0K |
| D | 2022-02-23 | 2022-02-21 | BSX | Monson Jonathan | VP, CAO, Gbl Ctrl | M - OptEx | $0.00 | +623 | 30.9K | +2% | $0 |
| D | 2022-02-23 | 2022-02-21 | BSX | Monson Jonathan | VP, CAO, Gbl Ctrl | F - Tax | $42.55 | -180 | 30.7K | -0.6% | -$7,659 |
| D | 2022-02-23 | 2022-02-21 | BSX | Fitzgerald Joseph Michael | EVP, Pres, Cardiology | F - Tax | $42.55 | -1,923 | 216.0K | -0.9% | -$81.8K |
| D | 2022-02-23 | 2022-02-21 | BSX | Fitzgerald Joseph Michael | EVP, Pres, Cardiology | M - OptEx | $0.00 | +3,895 | 218.0K | +2% | $0 |
| D | 2022-02-23 | 2022-02-21 | BSX | Brennan Daniel J. | EVP, CFO | F - Tax | $42.55 | -1,624 | 272.8K | -0.6% | -$69.1K |
| D | 2022-02-23 | 2022-02-21 | BSX | Brennan Daniel J. | EVP, CFO | M - OptEx | $0.00 | +3,661 | 274.4K | +1% | $0 |
| D | 2022-02-23 | 2022-02-21 | BSX | Scanlon Meghan | SVP, Pres, Urology Pelvic Health | F - Tax | $42.55 | -229 | 22.3K | -1% | -$9,744 |
| D | 2022-02-23 | 2022-02-21 | BSX | Scanlon Meghan | SVP, Pres, Urology Pelvic Health | M - OptEx | $0.00 | +779 | 22.5K | +4% | $0 |
| DM | 2022-02-22 | 2022-02-17+ | BSX | Nanavaty Maulik | SVP, Pres, Neuromodulation | M - OptEx | $0.00 | +3,945 | 174.7K | +2% | $0 |
| DM | 2022-02-22 | 2022-02-17+ | BSX | Nanavaty Maulik | SVP, Pres, Neuromodulation | F - Tax | $42.70 | -1,366 | 173.9K | -0.8% | -$58.3K |
| DM | 2022-02-22 | 2022-02-17+ | BSX | Monson Jonathan | VP, CAO, Gbl Ctrl | F - Tax | $42.73 | -560 | 30.3K | -2% | -$23.9K |
| DM | 2022-02-22 | 2022-02-17+ | BSX | Monson Jonathan | VP, CAO, Gbl Ctrl | M - OptEx | $0.00 | +1,637 | 30.2K | +6% | $0 |
| DM | 2022-02-22 | 2022-02-17+ | BSX | Meredith Ian T | EVP Gbl Chief Med Off | F - Tax | $42.70 | -672 | 33.2K | -2% | -$28.7K |
| DM | 2022-02-22 | 2022-02-17+ | BSX | Meredith Ian T | EVP Gbl Chief Med Off | M - OptEx | $0.00 | +2,287 | 32.9K | +7% | $0 |
| DM | 2022-02-22 | 2022-02-17+ | BSX | Sorenson John Bradley | SVP, Gbl Supply Chain | F - Tax | $42.71 | -822 | 34.6K | -2% | -$35.1K |
| DM | 2022-02-22 | 2022-02-17+ | BSX | Sorenson John Bradley | SVP, Gbl Supply Chain | M - OptEx | $0.00 | +2,686 | 35.1K | +8% | $0 |
| DM | 2022-02-22 | 2022-02-17+ | BSX | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | M - OptEx | $0.00 | +6,149 | 137.9K | +5% | $0 |
| DM | 2022-02-22 | 2022-02-17+ | BSX | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | F - Tax | $42.70 | -1,882 | 136.9K | -1% | -$80.4K |
| DM | 2022-02-22 | 2022-02-17+ | BSX | Thepaut Eric Francis Yves | EVP, Pres, Eur, Mid-East, Afr | F - Tax | $42.71 | -2,531 | 91.6K | -3% | -$108.1K |
| DM | 2022-02-22 | 2022-02-17+ | BSX | Thepaut Eric Francis Yves | EVP, Pres, Eur, Mid-East, Afr | M - OptEx | $0.00 | +4,501 | 92.1K | +5% | $0 |
Purchase Sale Sale after option exercise All abbreviations